Mabion (WAR:MAB) YoY EPS Growth : -250.75% (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Mabion YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Mabion's YoY EPS Growth for the quarter that ended in Sep. 2024 was -250.75%.

Mabion's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was zł-1.01.

Mabion YoY EPS Growth Historical Data

The historical data trend for Mabion's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabion YoY EPS Growth Chart

Mabion Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

11.79

12.50

102.96

1,091.67

78.32

Mabion Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EPS Growth	Get a 7-Day Free Trial															316.13	-108.25	3.92	-31.91	-250.75

Mabion YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Mabion's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(2.55	-	1.43)	/	\| 1.43 \|
=	78.32 %

Mabion's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EPS Growth (Q: Sep. 2024 )
=	(Earnings per Share (Diluted) (Q: Sep. 2024 )	-	Earnings per Share (Diluted) (Q: Sep. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Sep. 2023 )) \|
=	(-1.01	-	0.67)	/	\| 0.67 \|
=	-250.75 %

Mabion YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Mabion's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Mabion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabion SA (WAR:MAB) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Gen. Mariana Langiewicza 60, Konstantynow Lodzki, POL, 95-050

Website

https://www.mabion.eu

Mabion SA is a Polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology. The drugs developed by the company are targeted treatments, characterized by the drug's ability to recognize the factor causing cancer and interact with this factor only. The company is working on the development of its main priority drug, referred to as the MabionCD20 drug. The therapeutic uses of MabionCD20 are for Non-Hodgkin's lymphoma, Leukemia, and Rheumatoid Arthritis.